Expression of adhesion molecules in atopic dermatitis is reduced by tacrolimus, but not by hydrocortisone butyrate: A randomized immunohistochemical study

Clinical and Experimental Dermatology

Volumn 31, Issue 6, 2006, Pages 813-817

  Caproni, M ^a   Torchia, D ^a   Antiga, E ^a   Volpi, W ^a   Fabbri, P ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBODY; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HYDROCORTISONE BUTYRATE; INTERCELLULAR ADHESION MOLECULE 1; LOCOIDON; TACROLIMUS; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OINTMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SKIN BIOPSY; TOPICAL TREATMENT; TREATMENT DURATION;

ADULT; AGED; BIOPSY; CELL ADHESION MOLECULES; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; E-SELECTIN; HUMANS; HYDROCORTISONE; IMMUNOENZYME TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; INTERCELLULAR ADHESION MOLECULE-1; MIDDLE AGED; OINTMENTS; SKIN; TACROLIMUS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33749827073     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2006.02214.x     Document Type: Article

References (10)

1. Alomar A, Berth-Jones J, Bos JD et al. The role of topical calcineurin inhibitors in atopic dermatitis. Br J Dermatol 2004; 151 (Suppl. 70): 3-27.
2. Simon D, Vassina E, Yousefi S et al. Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment. J Allergy Clin Immunol 2004; 114: 887-95.
3. Park CW, Lee BH, Han HJ et al. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis. Br J Dermatol 2005; 152: 1173-81.
4. Jung K, Linse F, Eller R et al. Adhesion molecules in atopic dermatitis. VCAM-1 and ICAM-1 expression is increased in healthy-appearing skin. Allergy 1996; 51: 452-60.
5. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) Supplt 1980; 92: 44-7.
6. Sasakawa T, Sasakawa Y, Masunaga T et al. FK506 suppresses E-selectin, ICAM-1 and VCAM-1 expression on vascular endothelial cells by inhibiting tumor necrosis factor a secretion from peripheral blood mononuclear cells. Cytokine 2005; 29: 67-71.
7. Cronstein BN, Kimmel SC, Levin RI et al. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1992; 89: 9991-5.
8. Lemster B, Rilo HR, Carroll PB et al. FK 506 inhibits cytokine gene and adhesion molecule expression in psoriatic skin lesions. Ann N Y Acad Sci 1993; 696: 250-6.
9. Schramm R, Schaefer T, Menger MD, Thorlacius H. Acute mast cell-dependent neutrophil recruitment in the skin is mediated by KC and LFA-1: inhibitory mechanisms of dexamethasone. J Leukocyte Biol 2002; 72: 1122-32.
10. Wollenberg A, Sharma S, von Bubnoff D et al. Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. J Allergy Clin Immunol 2001; 107: 519-25.